Top Page
Australian Dairy Nutritionals Group
(Sydney:AHF)
Australian Dairy Nutritionals Group (AHF) vs. iShares MSCI Australia ETF (EWA)
Australian Dairy Nutritionals Group Business Overview & Revenue Model
Australian Dairy Nutritionals Group Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.53M | 7.17M | 6.18M | 5.86M | 5.80M | 21.30M |
| Gross Profit | -1.10M | -1.42M | -2.15M | -288.23K | -4.36M | -3.27M |
| EBITDA | -4.54M | -4.30M | -6.26M | -5.95M | -1.29M | -5.34M |
| Net Income | -4.42M | -5.21M | -7.36M | -9.16M | -4.15M | -6.40M |
Balance Sheet | ||||||
| Total Assets | 24.17M | 25.09M | 30.35M | 36.24M | 44.60M | 43.11M |
| Cash, Cash Equivalents and Short-Term Investments | 809.01K | 2.69M | 6.13M | 2.01M | 2.43M | 6.23M |
| Total Debt | 200.85K | 48.45K | 2.25M | 1.04M | 1.09M | 6.49M |
| Total Liabilities | 2.02M | 1.44M | 3.62M | 2.72M | 4.65M | 9.12M |
| Stockholders Equity | 22.31M | 23.85M | 26.87M | 33.59M | 16.05M | 33.99M |
Cash Flow | ||||||
| Free Cash Flow | -3.65M | -3.46M | -4.72M | -7.91M | -6.90M | -7.11M |
| Operating Cash Flow | -3.24M | -3.28M | -4.44M | -7.05M | -3.80M | -2.03M |
| Investing Cash Flow | -245.46K | -47.59K | 6.73M | 6.18M | 3.10M | 1.07M |
| Financing Cash Flow | -184.50K | -94.51K | 1.80M | 449.98K | -3.07M | 796.49K |
Australian Dairy Nutritionals Group Technical Analysis
Australian Dairy Nutritionals Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | AU$125.25M | 13.21 | 10.01% | 2.19% | 38.25% | 361.54% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | AU$107.30M | 17.11 | 13.97% | ― | 28.66% | ― | |
51 Neutral | AU$1.78B | 9.86 | 0.82% | 1.95% | 0.49% | -127.84% | |
40 Underperform | AU$22.55M | -5.27 | -20.54% | ― | 13.92% | 36.28% | |
40 Underperform | AU$31.87M | -0.37 | 19.78% | ― | 1.03% | -52.56% | |
40 Underperform | AU$20.39M | -2.06 | -41.69% | ― | 102.21% | 69.47% |
Australian Dairy Nutritionals Group Corporate Events
Australian Dairy Nutritionals Group has disclosed a change in director Peter Nathan’s interests, with his indirect holdings increasing through on-market share purchases. The transactions, executed via entities associated with Nathan between 2 and 4 March 2026, lifted his indirect stake to more than 15 million fully paid ordinary shares while his 3 million unlisted options remained unchanged.
The acquisitions, funded with cash consideration across three trades, signal a higher personal exposure to the company’s equity by a key board member. This incremental investment may be viewed by stakeholders as a vote of confidence in the company’s prospects and aligns director incentives more closely with those of other shareholders.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has disclosed a change in director Peter Nathan’s indirect interests, reflecting his increased shareholding through entities associated with his superannuation and family accounts. The move underscores the director’s deeper financial alignment with the company’s prospects and may be viewed by investors as a signal of confidence in its ongoing capital initiatives.
Nathan subscribed for 2,003,697 fully paid ordinary shares at AUD 0.028 per share under the company’s recently announced pro-rata non-renounceable entitlement offer. Following this transaction, his indirect holdings have risen across both related investment vehicles, consolidating his stake and reinforcing his exposure to future company performance and strategic developments.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Group has released its interim financial report for the half year ended 31 December 2025, detailing its financial performance, position, and cash flows over the period. The report, which includes directors’ commentary and an independent auditor’s review, provides stakeholders with updated visibility on the group’s operational and financial health, though specific results and strategic changes are not disclosed in the excerpt provided.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has applied for quotation on the ASX of 19,109,443 new fully paid ordinary shares under its existing issuer code AHF. The new securities, issued on 25 February 2026 and linked to a previously announced transaction, will expand the company’s listed capital base and may influence liquidity and shareholder positioning without altering its core dairy nutrition operations.
The move reflects ongoing capital management activities as the group continues to support its dairy nutrition growth strategy within the listed market framework. By increasing the volume of quoted shares, the company may enhance trading flexibility for investors while reinforcing its presence in the Australian equity market.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has completed its 1-for-6 pro rata non-renounceable entitlement offer, issuing 19,109,443 new shares and raising about $535,000 before costs, with total shares on issue increasing to 762,431,258. The company will allot and list the new shares immediately and retains the option to place the 104,777,527-share shortfall to investors within three months at no less than $0.028 per share, providing additional capital-raising flexibility that could support its operations and growth in the competitive dairy nutrition market.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer of fully paid ordinary shares at $0.028 per share to raise approximately $3.47 million, available only to shareholders with registered addresses in Australia, China, Hong Kong, and New Zealand who meet relevant securities law criteria. The company has formally notified overseas investors outside these jurisdictions that they are ineligible to participate due to the cost and complexity of complying with additional regulatory regimes, and because the potential capital from those holders would be relatively small; as the offer is non-renounceable, those ineligible shareholders will not receive any payment or value for the entitlements they would otherwise have received, effectively concentrating the capital-raising opportunity among its core regional investor base.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer to raise approximately A$3.47 million through the issue of new fully paid ordinary shares at A$0.028 per share to eligible shareholders on the 30 January 2026 record date. The new shares, which will rank equally with existing stock, are available to investors in Australia, China, Hong Kong and New Zealand, with the retail offer open from 4 to 18 February 2026 and the company warning that shareholders who do not participate may face dilution while those who do can also apply for additional shares subject to any shortfall, potentially widening the register and strengthening the group’s capital position.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer of fully paid ordinary shares at $0.028 per share to raise approximately $3.47 million. Eligible shareholders on the 30 January 2026 record date can subscribe for new shares and apply for additional shares under a top-up facility, with the company outlining that full take-up would leave control unchanged, while non-participating holders face potential dilution of up to about 14.3%. The board has committed to ensuring no investor’s holding exceeds 19.99% through the allocation of additional shares and any required pro rata scale-back, and expects that no shareholder will hold 20% or more on completion of the offer, limiting any significant change in control dynamics.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has announced a proposed non-renounceable pro rata issue of up to 123,886,970 fully paid ordinary shares, with an ex-date of 29 January 2026, a record date of 30 January 2026, and an expected issue date of 25 February 2026. The capital raising will expand the company’s equity base and could provide additional funding flexibility for its dairy nutrition operations, with implications for existing shareholders’ holdings through dilution but also potential support for future growth initiatives and balance sheet strength.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has launched a pro-rata non-renounceable entitlement offer to raise approximately A$3.47 million by issuing up to 123.9 million new shares at A$0.028 each, allowing eligible shareholders in Australia, New Zealand, Hong Kong and China to subscribe for one new share for every six held. The capital raising, which includes a top-up facility and potential placement of any shortfall at the board’s discretion, is aimed at funding capital equipment to improve processing efficiency, supporting the company’s growth strategy in China, and providing additional working capital, underscoring a push to accelerate expansion in 2026 while prioritising participation by existing shareholders.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Limited has requested and been granted a trading halt on its securities on the ASX while it prepares an announcement regarding a proposed capital raising. The company has indicated that the capital raising will be material to its operations, with trading expected to resume by 27 January 2026 or upon release of the funding details, signaling a potentially significant move to strengthen its balance sheet or support future growth initiatives.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.
Australian Dairy Nutritionals Group reported Q2 FY26 consolidated revenue of $1.4 million, with nutritional powder sales of $776,000 up 152% on the prior corresponding period, driven by expanded distribution of its Future brand in China and contract packing. Overall quarterly revenue was down 19% year-on-year due to stock returns following unexpected regulatory and packaging changes in Vietnam and lower milk and livestock sales after exiting the North Brucknell farm lease, although first-half FY26 revenue remains 15% ahead of the prior year. The company posted operating cash outflows of $1.11 million for the quarter and finished with $809,000 in cash after the expiry of a $1.22 million funding facility, leaving it without that secured line, while directors’ remuneration remained steady at $80,000. Management is banking on continued distribution growth of the Future brand via China’s o2o M2C global shopping app, with presence now in seven provinces and a target of 1,000 active stores by the end of FY26, alongside the anticipated resumption of shipments to Vietnam once revised packaging is in place, to accelerate revenue growth in the second half and underpin its positioning in Asian nutritional powder markets.
The most recent analyst rating on (AU:AHF) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Australian Dairy Nutritionals Group stock, see the AU:AHF Stock Forecast page.